95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-9.14%
Negative revenue growth while FSM stands at 6.64%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-3.04%
Negative gross profit growth while FSM is at 55.25%. Joel Greenblatt would examine cost competitiveness or demand decline.
-1.06%
Negative EBIT growth while FSM is at 95.51%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1.06%
Negative operating income growth while FSM is at 95.51%. Joel Greenblatt would press for urgent turnaround measures.
-32.95%
Negative net income growth while FSM stands at 106.78%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-32.43%
Negative EPS growth while FSM is at 106.82%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-32.43%
Negative diluted EPS growth while FSM is at 106.76%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.07%
Share count expansion well above FSM's 0.01%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.08%
Diluted share reduction more than 1.5x FSM's 0.73%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-100.00%
Dividend reduction while FSM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-21.46%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-60.38%
Negative FCF growth while FSM is at 16.52%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-18.34%
Negative 10Y revenue/share CAGR while FSM stands at 86.23%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
5.34%
5Y revenue/share CAGR under 50% of FSM's 37.15%. Michael Burry would suspect a significant competitive gap or product weakness.
-16.68%
Negative 3Y CAGR while FSM stands at 104.14%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-36.08%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
5.49%
Below 50% of FSM's 14.38%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-24.69%
Negative 3Y OCF/share CAGR while FSM stands at 74.56%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-34.59%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
60.03%
Positive 5Y CAGR while FSM is negative. John Neff might view this as a strong mid-term relative advantage.
16.20%
Below 50% of FSM's 233.63%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
65.46%
10Y equity/share CAGR at 50-75% of FSM's 99.36%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
35.36%
5Y equity/share CAGR above 1.5x FSM's 19.48%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
28.74%
3Y equity/share CAGR above 1.5x FSM's 9.94%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.98%
Firm’s AR is declining while FSM shows 231.12%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-37.75%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.15%
Asset growth at 50-75% of FSM's 3.72%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
1.34%
BV/share growth above 1.5x FSM's 0.89%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-10.20%
We’re deleveraging while FSM stands at 23.06%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
6.88%
We expand SG&A while FSM cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.